These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9613785)

  • 1. Analysis of the value of empiric vancomycin administration in febrile neutropenia occurring after autologous peripheral blood stem cell transplants.
    Koya R; Andersen J; Fernandez H; Goodman M; Spector N; Smith R; Hanlon J; Cassileth PA
    Bone Marrow Transplant; 1998 May; 21(9):923-6. PubMed ID: 9613785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Febrile neutropenia in paediatric peripheral blood stem cell transplantation, in -vitro sensitivity data and clinical response to empirical antibiotic therapy.
    Ansari SH; Nasim S; Ahmed A; Irfan M; Ishaque A; Farzana T; Panjwani VK; Taj M; Shamsi TS
    J Coll Physicians Surg Pak; 2006 Nov; 16(11):704-8. PubMed ID: 17052420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF.
    Offidani M; Corvatta L; Olivieri A; Rupoli S; Frayfer J; Mele A; Manso E; Montanari M; Centurioni R; Leoni P
    Bone Marrow Transplant; 1999 Nov; 24(10):1079-87. PubMed ID: 10578158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies.
    Celebi H; Akan H; Akçağlayan E; Ustün C; Arat M
    Bone Marrow Transplant; 2000 Jul; 26(2):211-4. PubMed ID: 10918433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
    Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
    Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Imipenem combined with teicoplanin or vancomycin in the initial empirical treatment of febrile neutropenia. Analysis of the primary response and of a global sequential strategy in 126 episodes].
    Figuera A; Tomás JF; Hernández L; Jiménez ML; Peñarrubia MJ; del Rey MC; Arranz R; Cámara R; López-Lorenzo JL; Fernández-Rañada JM
    Rev Clin Esp; 1996 Aug; 196(8):515-22. PubMed ID: 8984537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of mono-antibiotic therapy using piperacillin associated with sulbactam and possibly followed by vancomycin in febrile neutropenia in solid tumors].
    Abs L; Kattan J; Culine S; Bekradda M; Farhat F; Droz JP
    Bull Cancer; 1994 Oct; 81(10):871-6. PubMed ID: 7734770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
    Vázquez L; Encinas MP; Morín LS; Vilches P; Gutiérrez N; García-Sanz R; Caballero D; Hurlé AD
    Haematologica; 1999 Mar; 84(3):231-6. PubMed ID: 10189388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
    Raad II; Escalante C; Hachem RY; Hanna HA; Husni R; Afif C; Boktour MR; Whimbey EE; Kontoyiannis D; Jacobson K; Kantarjian H; Levett LM; Rolston KV
    Cancer; 2003 Sep; 98(5):1039-47. PubMed ID: 12942573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefepime versus ticarcillin and clavulanate potassium and aztreonam for febrile neutropenia therapy in high-dose chemotherapy patients.
    Fleming DR; Ziegler C; Baize T; Mudd L; Goldsmith GH; Herzig RH
    Am J Clin Oncol; 2003 Jun; 26(3):285-8. PubMed ID: 12796602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation.
    Kapur D; Dorsky D; Feingold JM; Bona RD; Edwards RL; Aslanzadeh J; Tutschka PJ; Bilgrami S
    Bone Marrow Transplant; 2000 Jan; 25(2):147-52. PubMed ID: 10673672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial.
    Harter C; Schulze B; Goldschmidt H; Benner A; Geiss HK; Hoppe-Tichy T; Ho AD; Egerer G
    Bone Marrow Transplant; 2006 Feb; 37(4):373-9. PubMed ID: 16400334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin does not benefit persistently febrile neutropenic people with cancer.
    Wade JC; Glasmacher A
    Cancer Treat Rev; 2004 Feb; 30(1):119-26. PubMed ID: 14766129
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial.
    Eleutherakis-Papaiakovou E; Kostis E; Migkou M; Christoulas D; Terpos E; Gavriatopoulou M; Roussou M; Bournakis E; Kastritis E; Efstathiou E; Dimopoulos MA; Papadimitriou CA
    Am J Hematol; 2010 Nov; 85(11):863-7. PubMed ID: 20882526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of obtaining blood cultures in febrile neutropenic patients undergoing bone marrow transplantation.
    Serody JS; Berrey MM; Albritton K; O'Brien SM; Capel EP; Bigelow SH; Weber DJ; Gabriel ; Wiley JM; Schell MJ; Gilligan PH; Shea TC
    Bone Marrow Transplant; 2000 Sep; 26(5):533-8. PubMed ID: 11019843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized comparison of empiric or pre-emptive antibiotic therapy after hematopoietic stem cell transplantation.
    Slavin MA; Grigg AP; Schwarer AP; Szer J; Spencer A; Sainani A; Thursky KA; Roberts AW
    Bone Marrow Transplant; 2007 Jul; 40(2):157-63. PubMed ID: 17468774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Febrile neutropenia. Etiology of infection, empirical treatment and prophylaxis.
    Eltahawy AT
    Saudi Med J; 2003 Apr; 24(4):331-6. PubMed ID: 12754528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended follow-up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unit.
    Cumpston A; Craig M; Hamadani M; Abraham J; Hobbs GR; Sarwari AR
    Transpl Infect Dis; 2013 Apr; 15(2):142-9. PubMed ID: 23279656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of early neutropenic fever, with or without bacterial infection, is still a significant complication after reduced-intensity stem cell transplantation.
    Hori A; Kami M; Kim SW; Chizuka A; Kojima R; Imataki O; Sakiyama M; Hamaki T; Onishi Y; Usubuchi N; Kishi Y; Murashige N; Tajima K; Miyakoshi S; Heike Y; Masuo S; Taniguchi S; Takaue Y
    Biol Blood Marrow Transplant; 2004 Jan; 10(1):65-72. PubMed ID: 14752781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerobic bacterial and fungal infections in peripheral blood stem cell transplants.
    Aksu G; Ruhi MZ; Akan H; Bengisun S; Ustün C; Arslan O; Ozenci H
    Bone Marrow Transplant; 2001 Jan; 27(2):201-5. PubMed ID: 11281391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.